ES453907A1 - Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES453907A1
ES453907A1 ES453907A ES453907A ES453907A1 ES 453907 A1 ES453907 A1 ES 453907A1 ES 453907 A ES453907 A ES 453907A ES 453907 A ES453907 A ES 453907A ES 453907 A1 ES453907 A1 ES 453907A1
Authority
ES
Spain
Prior art keywords
moiety
formula
derivatives
trifluoromethyl
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES453907A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to ES453907A priority Critical patent/ES453907A1/en
Publication of ES453907A1 publication Critical patent/ES453907A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Procedure for the preparation of pyrazolone derivatives of general formula I **(See formula)** where R1 signifies hydrogen, trifluoromethyl or an alkyl, aryl, aralkyl or heteroaryl moiety, where the above mentioned moieties may optionally be substituted and R2, in the event that R1 signifies hydrogen, trifluoromethyl, alkyl with more than 4 carbon atoms, substituted heteroaryl or aryl or aralkyl, means an unsubstituted naphthyl residue, and, otherwise, R2 means a substituted naphthyl residue, which can have 1 to 3 equal or different substituents of the halogen, trifluoromethyl, alkyl, alkenyl, alkoxy, alkylamino group., cyano, trifluoromethoxy, nitro, hydroxy, SOn-alkyl (n = 0 to 2) or SOn-trifluoromethyl (n = 0 to 2), where optionally two substituents on the aryl moiety together signify an isocyclic or heterocyclic ring, 5- to 7-membered, branched or unbranched, saturated or unsaturated, which may contain 1 to 2 oxygen or sulfur atoms, or a biphenyl moiety, characterized in that A) hydrazines of formula II R2-O-CH2-OH2-NH-NH2 (II) where R2 has the meaning indicated above, they are reacted with derivatives of the β-keto acid of formula III **(See formula)** where R1 has the meaning indicated above, and X means a protruding moiety, such as the hydroxy, alkoxy, aralkoxy, amino or alkylamino moiety, optionally in the presence of inert solvents and basic or acidic catalysts, such as alkali hydroxides and carbonates and alkaline earth, or such as hydrohalic acids, sulfuric acid or sulfonic acids, at temperatures between 10 and 200ºC, or B) Naphthoxyethyl derivatives of formula IV R2 - O - CH2 - CH2 - A (IV) where R2 has the meaning of above and A means a leaving moiety, such as halogen or the dialkyloxonium, dialkylsulfonium or trialkylammonium moiety or the aryl or trifluoromethyl sulphonic acid moiety, with pyrazolone derivatives (5) of formula V **(See formula)** where R1 has the meaning indicated above, optionally in the presence of inert solvents and inorganic or organic bases, such as alkali hydroxides, carbonates, alcoholates, hydrides or amides, at temperatures between 10 and 200ºC, or C) derivatives of acetylenecarboxylic acid of formula VI **(See formula)** where R1 has the meaning of above and Z2 means a hydroxy, alkoxy, aralkoxy, amino or alkylamino moiety, it is reacted with hydrazine of formula II R2 - O - CH2 - CH2 - NH - NH2 II where R2 has the meaning above, optionally in the presence of an inert solvent and inorganic or organic bases at temperatures between 50º and 200ºC. (Machine-translation by Google Translate, not legally binding)
ES453907A 1976-12-03 1976-12-03 Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding) Expired ES453907A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES453907A ES453907A1 (en) 1976-12-03 1976-12-03 Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES453907A ES453907A1 (en) 1976-12-03 1976-12-03 Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding)

Publications (1)

Publication Number Publication Date
ES453907A1 true ES453907A1 (en) 1977-11-16

Family

ID=8472715

Family Applications (1)

Application Number Title Priority Date Filing Date
ES453907A Expired ES453907A1 (en) 1976-12-03 1976-12-03 Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding)

Country Status (1)

Country Link
ES (1) ES453907A1 (en)

Similar Documents

Publication Publication Date Title
GB1563842A (en) Phenyl-acetic acids and derivatives thereof
KR880000439A (en) Method for preparing 1,8-bridged 4-quinolone-3-carboxylic acid
ES425373A1 (en) Pyrazol-5-ones
KR840000508A (en) Method for preparing 4-anilinopyrimidine derivative
KR840001146A (en) Method for preparing 4-methyl 6-phenyl pyridazine derivative
ES453907A1 (en) Procedure for the preparation of pirazolone derivatives. (Machine-translation by Google Translate, not legally binding)
ES453908A1 (en) Production of pyrazolone derivatives and use of the same as pharmaceutical agent
ES328674A1 (en) Procedure for the production of alcaloids. (Machine-translation by Google Translate, not legally binding)
ES416167A1 (en) 3-amino-pyrazolones-5, processes for their manufacture and their use as medicines
Dupre et al. An improved synthesis of ethyl N-(methoxycarbonyl)-2, 5-dihydro-1H-pyrrole-3-carboxylate
SE7600585L (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEFALOSPORANIC ACID DERIVATIVES
Just et al. The Use of the O-Nitrocinnamoyl Group as an Amine Blocking Function
US3121716A (en) Pyrazinamide and derivatives thereof
SE7605200L (en) METHOD OF PREPARING 2-SUBSTITUTED 1,4-BENZODIAZEPIN DERIVATIVES
Milani et al. 2, 2, 2-Trifluoroethylnitroguanidine1
KR790001686B1 (en) Process for the preparation of 5-benzyl picolinic acids
ES8201138A1 (en) Improved procedure for the preparation of carbostiril derivatives (Machine-translation by Google Translate, not legally binding)
EP0790238A2 (en) Process for preparing 1,1-disubstituted-1h-benzo[e]indole derivatives and hydroxyl-substituted 1,1-disubstituted-1H-benzo[e]indole derivatives
JPS5692265A (en) Production of optically active thioglycolic acid derivative
ES448168A1 (en) Pyrimidines and in their preparation
GB1204459A (en) Process for the production of 4,4'-dihydroxytetraphenyl methane
山中宏 Studies on 4-Alkoxy-6-methyl-pyrimidine N-Oxides.
JPS5522649A (en) Preparation of rifamycin derivative
JPS5513215A (en) Preparation of 1-(5-oxohexyl)-3,7-dimethylxanthine
ES445255A1 (en) A procedure for the preparation of 3-substitute methyl-2 or 3cefem-4-carboxylic acids. (Machine-translation by Google Translate, not legally binding)